Tohda Chihiro

2020 - 2022 Development of anti-Alzheimer's disease based on a ubiquitin-proteasome activator

2017 - 2022 Drug therapy of chronic phase of spinal cord injury; development of botanical drugs to improve muscle atrophy and axonal disruption

2018 - 2021 Development of therapeutic strategy for Alzheimer's disease via M2 microglia

2016 - 2019 Mode-of-action analysis of Kampo formulae and prediction of their new indications for a wide range of diseases

2015 - 2019 Search for marine natural products that act on "cellular machinery" on cell surface

2016 - 2018 神経回路網の再構築による認知症予防・改善のための機能性表示食品の開発

2015 - 2018 Study on medicinal plants in Asia for sustainable use of traditional medicines

2014 - 2017 Traditional medicine-based drug development-creation of new paradigm-

2013 - 2016 Design, Synthesis, and Structure-Activity Relationship Study of Novel Neuro-Protecting Drugs Based on Natural Product Hybridization

2012 - 2015 Construction of a program for sustainable use of traditional medicines, based on integrated study of genetic, chemical and pharmacological diversity of medicinal plants

2009 - 2014 Studies for the detail mechanisms of depression onset and the development of novel antidepressants based on "the Wakan-yaku, Sino-Japanese traditional medicine, theory"

2011 - 2014 富山県産和漢薬から開発する脊髄損傷改善薬に関する研究

2012 - 2013 アルツハイマー病を改善する新しい薬物とその分子機序

2011 - 2013 Recovery from spinal cord injury in the chronic phase -the mechanism of denosomin, a novel compound with multiactivities-

2009 - 2011 Analysis on genetic, chemical and pharmacological diversity of medicinal plants, towards sustainable uses of traditional medicines

2009 - 2011 Development of Novel Methodology for the Synthesis of 2, 3-Benzodiazepines and Application for Neuro-therapeutic Agents

2009 - 2010 新規薬物Denosominによる「むずむず脚症候群」原因遺伝子を介した脊髄損傷改善作用

2009 - 2010 伝統薬物研究から展開する神経創薬戦略-アルツハイマー病と脊髄損傷を克服する画期的な治療薬開発の実現に向かう研究-

2008 - 2010 Frontal lobe pathology in schizophrenia : its pathogenesis and the development of the drug

2007 - 2008 神経変性疾患に有効な伝統薬物分子の探索とその治療戦略

2005 - 2007 Identification of the intrinsic molecules which are involved in the generation of disease, and the analysis of the molecular mechanisms and functions, by using Wakan-yaku, Japanese traditional systematized medicine

2005 - 2007 Investigation on Kampo Drug Resources in Asia and Analysis on Diversity ofMedicinal Plants

2005 - 2007 Study of the molecular mechanism of synaptogenesis using withanolides, novel anti-dementia drugs

2005 - 2006 漢方処方を進化させる科学的アプローチ-痴呆を治療する処方の開発-

2005 - ADHD(注意欠陥多動性障害)の病態形成と脳内PI3 kinaseとの関連

2005 - Relation of PI3 kinase to ADHD etiology

2003 - 2004 漢方薬の作用機序を分子レベルで解明する新しいストラテジーの確立

2003 - 2004 薬物の作用機序を分子レベルで解明する新しい戦略 ~痴呆根治薬の解析への応用と、和漢薬研究におけるブレイクスルー

2002 - 2004 Inquiry into Kampo Drug Resources of Asia : Investigation on Mongolian and Thai Medicinal Plants

2002 - 2003 神経回路網再形成型の新しい抗痴呆薬~漢方方剤“続命湯”の作用~

2002 - 2003 mRNA動態の新概念~神経軸索を輸送されるmRNAの存在と神経回路網形成への関与

2001 - 2002 神経軸索終末に輸送されるmRNAのクローニング〜軸索形成に関与する因子の解析〜

2000 - 2001 「インド生薬Ashwagandha (Withania somnifera)中の神経回路網再生因子~作用機序の解明と抗痴呆薬への展開~」

1999 - 2001 Comparative Ethnopharmacology in China

1999 - 2000 新規因子sproutinの神経ネットワーク賦活化と痴呆の改善に及ぼす作用

1998 - 2000 MECHANISMS OF ALLERGIC ITCH

1997 - 1998 アトピー性皮膚炎の痒みに関連した因子の単離、同定および機能解析

1998 - 神経変性疾患(アルツハイマー病、脊髄損傷)を克服する治療薬の伝統薬物からの単離・同定、およびその作用機序解明による病態制分子の解析

1998 - Study of pathological mechanism of neurodegenerated diseases (Alzheimer's disease, spinal cord injury)and therapeutic strategy

神経可塑型性メカニズムに関する研究

Study on a mechanism of neuronal plasticity